CFTR and cystic fibrosis: Studies have shown that, if produced at sufficient levels, CFTR-W1282X protein is responsive to current CFTR modulator therapies (17, 19, 20, 22, 23), but because stop mutations in CFTR result in a dramatic loss of CFTR expression, CF patients are not usually responsive to these drugs.